Ticker

Analyst Price Targets — IRMD

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
February 11, 2026 1:44 pmLake Street$120.00$106.02TheFly iRadimed price target raised to $120 from $100 at Lake Street
February 10, 2026 8:36 pmRoth Capital$120.00$105.15TheFly iRadimed price target raised to $120 from $98 at Roth Capital
November 3, 2025 8:10 pmKyle BauserRoth Capital$98.00$84.11TheFly iRadimed price target raised to $98 from $90 at Roth Capital
November 3, 2025 6:28 pmLake Street$100.00$84.11TheFly iRadimed price target raised to $100 from $75 at Lake Street
October 31, 2025 8:24 amKyle BauserRoth Capital$90.00$76.42TheFly iRadimed resumed with a Buy at Roth Capital
August 2, 2024 8:40 amJason WittesRoth Capital$60.00$46.15TheFly iRadimed price target lowered to $60 from $65 at Roth MKM
June 17, 2024 9:49 amFrank TakkinenLoop Capital Markets$60.00$43.29StreetInsider Lake Street Capital Markets Reiterates Buy Rating on IRadimed Corp (IRMD)

Latest News for IRMD

IRADIMED CORPORATION to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

ORLANDO, Fla., May 20, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in developing innovative MRI-compatible medical devices, today announced that Roger Susi, President and Chief Executive Officer, and Jack Glenn, Chief Financial Officer, will attend the Goldman Sachs 47th Annual Global Healthcare Conference, to be held June 8–10, 2026, at the Loews Miami Beach Hotel, Miami Beach, Florida.

GlobeNewsWire • May 20, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for IRMD.

No House trades found for IRMD.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top